A 4.000 € way to improve perceived quality and meet expectations of thyroid cancer patients receiving therapeutic dose of Iodine-131

Nucl Med Rev Cent East Eur. 2022;25(2):138-140. doi: 10.5603/NMR.a2022.0031.

Abstract

Background: Thyroid cancer is the most common malignant disease of the endocrine system and radioiodine therapy (RAIT) is still very often used, resulting in patients staying hospitalized for a few days alone and without visitors, augmenting their stress and discomfort. Our objective was to find simple ways of improving RAIT patients' feelings and perceived quality of the nuclear medicine (NM) department services.

Material and methods: We designed a two-year study in order to enhance RAIT patients' perceived quality of the nuclear medicine (NM) department services and expectations' fulfillment. A questionnaire was used in order to capture patients' perceived quality and expectations from their RAIT.

Results: 549 replies were collected. Many intrinsic and extrinsic determinants were found to be positively or negatively related to the perceived quality and fulfillment of patients' expectations of receiving RAIT. A 1% increase could be achieved by spending 110 € per RAIT room.

Conclusions: In this article, we present some easily implemented changes in both personnel behavior and room amenities that could, at least in theory and based on our results, offer a 37.9% improvement in RAIT patients' perceived quality and expectations' fulfillment at a cost of 4169 €.

Keywords: RAIT; perceived quality; thyroid cancer.

MeSH terms

  • Humans
  • Iodine Radioisotopes* / therapeutic use
  • Motivation
  • Radionuclide Imaging
  • Thyroid Neoplasms* / diagnostic imaging
  • Thyroid Neoplasms* / radiotherapy

Substances

  • Iodine Radioisotopes
  • Iodine-131